Sponsors (14)
The bill directs targeted, short‑term federal funding, clearer definitions, and oversight to expand veteran TBI/mTBI research and access to evidence‑based care, but does so with limited, time‑bound resources that may strain VA budgets, favor larger institutions, create administrative burdens, and risk discontinuities or coverage gaps for some veterans and providers.
Veterans with TBI or chronic mTBI gain clearer access to and opportunities to receive new, evidence‑based treatments through funded clinical trials and applied programs.
Researchers, academic centers, and nonprofit partners receive dedicated, predictable funding and grant awards (including per‑grant limits) that expand TBI research capacity and support clinical trials.
Clinicians and VA providers get training, outreach resources, and clearer program guidance that should improve detection, diagnosis, and quality of care for mTBI/TBI.
Taxpayers and the VA face new spending obligations and potential budgetary pressure (authorized amounts in the bill) that could divert resources from other VA mental‑health priorities.
Programs are time‑limited (three‑year pilots/sunsets), risking interruption of care, loss of research momentum, and uncertainty about long‑term treatment development unless renewed or scaled.
Authorized annual appropriations and program funding levels (as written) may be insufficient relative to the scale of TBI/mTBI research and care needs, leaving promising projects unfunded.
Based on analysis of 4 sections of legislative text.
Creates two VA grant programs funding clinical trials and research for veteran TBI care and neurorehabilitation, authorizing $30M (Innovation) plus $10M/year (Research) for FY2026–FY2028.
Establishes two Department of Veterans Affairs grant programs to fund research, clinical trials, and patient‑facing neurorehabilitation treatments for traumatic brain injury (TBI) in veterans. One program (TBI Innovation Grant Program) awards grants up to $5,000,000 per entity for randomized controlled trials, non‑pharmacological treatments, clinician training, and partnerships; the second funds smaller exploratory and collaborative research grants administered with an independent third party. The bill authorizes funding through fiscal year 2028 ($30 million for the innovation program and $10 million per year for the research program), requires program regulations, reporting, evaluation, and a termination of program authority three years after enactment.
Official title: To direct the Secretary of Veterans Affairs to carry out programs to award grants to eligible entities to conduct research with respect to treatments for traumatic brain injury prospective randomized control trials for neurorehabilitation treatments, and for other purposes.
Introduced January 9, 2026 by John Bergman · Last progress January 9, 2026